Pinatuzumab vedotin
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | CD22 |
Clinical data | |
Synonyms | DCDT2980S, FCU2703 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Chemical and physical data | |
Formula | C6748H10377N1773O2083S44 |
Molar mass | 151.1 kg/mol |
Pinatuzumab vedotin (DCDT2980S, FCU2703) (INN[1]) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.